跳至主要内容
临床试验/NCT02246400
NCT02246400已完成不适用

CardioMetabolic Program Meets eHealth: Redesign and Evaluation for Optimal Reach and Impact

Palo Alto Medical Foundation1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2014年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
74
试验地点
1
主要终点
Change in measure of Health-related quality of life from baseline to 6-months follow up.

研究概览

简要总结

The eCMP Pilot aims to study the feasibility and potential effectiveness of an electronically-mediated CardioMetabolic Program (eCMP) for therapeutic lifestyle change among adults with or at high risk for type 2 diabetes, heart disease, and/or stroke.

详细描述

The eCMP is an evidence-based lifestyle intervention using a holistic, mind-body-spirit-based, and multidisciplinary approach, and it will be delivered using existing web and mobile technologies. In this pragmatic randomized controlled trial, participants will be recruited from primary care patients of an integrated ambulatory care system. They will be randomly assigned to receive the eCMP upon completion of baseline data collection (the Immediate Intervention group) or after 3 months (the Delayed Intervention group). All participants will be assessed at 0, 3 and 6 months. Outcomes include common cardiometabolic risk factors (e.g., weight, blood pressure, and fasting plasma glucose), health behaviors (e.g., dietary intake and physical activity), and indicators of eCMP engagement and adherence (e.g., attendance and self-monitoring).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •English-speaking adults aged 18+ years
  • •High-risk primary prevention: BMI 35+ and prediabetes (including hx of gestational diabetes) and/or metabolic syndrome
  • •Secondary prevention: BMI 30+ and type 2 diabetes and/or cardiovascular disease
  • •Able and willing to provide written informed consent

排除标准

  • •Medical determination that the study is inappropriate or unsafe for the patient
  • •Type 1 diabetes
  • •Safety concerns related to significant physical or mental health issues or life expectancy of less than 12 months
  • •Currently pregnant or lactating
  • •No regular telephone or broadband Internet access or otherwise unable to participate in the intervention

研究组 & 干预措施

Delayed Intervention

Active Comparator

Usual care for first three months. Initiation of the eCMP after the 3-month time point.

干预措施: eCMP (Behavioral)

Immediate Intervention

Experimental

Initiation of the eCMP immediately upon completion of baseline data collection and randomization

干预措施: eCMP (Behavioral)

结局指标

主要结局

Change in measure of Health-related quality of life from baseline to 6-months follow up.

时间窗: 6-months

SF-8 questionnaire

次要结局

  • Change in composite measure of Metabolic Syndrome(6-months.)
  • Dietary Intake(Baseline, 3-months, and 6-months.)
  • Intervention adherence(3-months and 6-months.)
  • Body weight(Baseline, 3 months, and 6 months)
  • Physical Activity(Baseline, 3-months, and 6-months.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验